ChromaDex (United States)
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for ChromaDex (United States), United States, covering academic research published from 2003 to 2025. Read More.
Open Access Percentage
59%
Total
Publications
83
Total Open
Publications
49
Total
Citations
3.3K
Open Access
Percentage
59%
Total
Publications
83
Total Open
Publications
49
Total
Citations
3.3K
Breakdown
Publisher Open
25%
Both
28%
Other Platform Open
5%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
13
Hybrid 36%
15
No Guarantees 33%
14
Other Platform Open
Domain 69%
18
Institution 54%
14
Other Internet 8%
2
Preprint 4%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 18 |
doaj.org OAI-PMH Repository | Institution | 6 |
Unknown Repository | Other Internet | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
National Institutes of Health | Institution | 2 |
Erasmus University Rotterdam | Institution | 2 |
ZB MED - Information Centre for Life Sciences | Institution | 1 |
University of Oslo | Institution | 1 |
University of Florence | Institution | 1 |
University of Copenhagen | Institution | 1 |